Stanley T. Crooke

GPTKB entity

Statements (42)
Predicate Object
gptkbp:instance_of gptkb:Person
gptkbp:advocates_for personalized medicine
gptkbp:affiliation gptkb:Ionis_Pharmaceuticals
gptkbp:alma_mater gptkb:University_of_California,_San_Francisco
gptkbp:awards multiple patents in drug development
gptkbp:birth_place gptkb:United_States
gptkbp:children not publicly disclosed
gptkbp:collaborated_with various academic institutions
gptkbp:contribution advancing genetic therapies
development of antisense oligonucleotide drugs
gptkbp:education gptkb:University_of_California,_San_Diego
gptkbp:field pharmaceutical research
gptkbp:founded Ionis Pharmaceuticals in 1989
gptkbp:goal improving patient outcomes
https://www.w3.org/2000/01/rdf-schema#label Stanley T. Crooke
gptkbp:impact advancements in RNA therapeutics
gptkbp:influence drug discovery processes
gptkbp:influenced pharmaceutical industry practices
gptkbp:influenced_by gptkb:Robert_W._Holley
gptkbp:inspiration in the field of biomedicine
gptkbp:invention over 100 patents
first FDA-approved antisense drug
gptkbp:involvement biotechnology sector
gptkbp:known_for antisense technology
founding Ionis Pharmaceuticals
gptkbp:leadership gptkb:Ionis_Pharmaceuticals
innovative and collaborative
gptkbp:legacy pioneering work in antisense technology
gptkbp:nationality gptkb:American
gptkbp:occupation gptkb:Scientist
gptkbp:philosophy patient-centered drug development
gptkbp:position CEO of Ionis Pharmaceuticals
gptkbp:publications numerous scientific articles
gptkbp:recognition leader in RNA therapeutics
gptkbp:research_areas genetic medicine
gptkbp:research_focus RNA-targeted therapeutics
gptkbp:spouse not publicly disclosed
gptkbp:vision transforming medicine through RNA technology
gptkbp:years_active 1980s-present
gptkbp:bfsParent gptkb:Ionis_Pharmaceuticals
gptkb:SGMO
gptkbp:bfsLayer 5